Third week of April is Minority Cancer Awareness Week
“Let’s Achieve Health Equity”
More information coming soon!
Posted August 30, 2024
When it comes to cancer disparities, community may count. That’s the finding of a new study published Aug. 21 in the Journal of the National Cancer Institute, which was led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, together with the American Cancer Society. The study... Read More »
Posted August 19, 2024
This interactive discussion of the third AACR Cancer Disparities Progress Report features researchers on cancer disparities and survivors sharing their experiences. The report highlights the latest research on cancer disparities and the progress and challenges to achieving cancer health equity. Find the full report at cancerdisparitiesprogressreport.org Watch HERE>>> Read More »
Posted April 8, 2024
A major goal of public health is to reduce health disparities. The programs described in the MMWR Supplement, Strategies for Reducing Health Disparities—Selected CDC-Sponsored Interventions, United States, 2016, are examples of CDC-sponsored initiatives that address health disparities with the goal of advancing health equity. Read More »
Posted December 29, 2023
In a new report, ASCO highlighted progress that has been made toward reducing disparities in cancer health among sexual and gender minority (SGM) individuals, although they stressed that additional progress is still needed in this area. The report, which was published in JCO Oncology Practice, served as an update on ASCO’s 2017 position statement “Strategies... Read More »
Posted June 14, 2023
Accrual of the S1826 clinical trial for advanced Hodgkin lymphoma will likely shift treatment modality. Remarkable was the diversity reported for the collaborative study for the first time of the adult and pediatric cooperative research groups.It was the largest Hodgkin lymphoma trial conducted by the National Clinical Trials Network (NCTN) with a highly representative group:... Read More »
Posted May 11, 2023
We firmly believe that embracing diversity and inclusion (D&I) drives innovation, improves scientific and clinical outcomes, and contributes to equitable healthcare access for all. Here at Genentech, that means fostering belonging within our own walls, advancing inclusive research and health equity in our industry at-large, and transforming society through partnerships across healthcare, education and within all communities. Please learn more HERE. Read More »
Posted April 9, 2023
CancerCoachLive partners with leading clinical specialists and advocacy organizations to bring free online education to cancer patients and caregivers. CancerCoachLive’s programs are broadcast live through our virtual learning channel, including a panel of experts, interactive Q&A, polling and slides for an immersive learning experience. All of their programmings are available on demand following the live... Read More »
Posted February 1, 2023
“Racial and ethnic minorities who are traditionally underrepresented in clinical trials have also had worse clinical outcomes over time. Black patients, for example, have a clinical trial enrollment rate of 4%-6% despite representing 15% of the population and have the highest overall cancer death rate. It has been established that numerous barriers to clinical trial participation exist at... Read More »
Cancer Treatment Disparities | AACR Cancer Disparities Progess Report 2020
American Cancer Society’s report on the status of cancer disparities in the United States, 2021.
Cancer statistics for African American/Black People 2022
Cancer statistics for the US Hispanic/Latino population, 2021
AACR REPORT ON THE IMPACT OF COVID-19 ON CANCER RESEARCH AND PATIENT CARE
Advancing Health Equity: A Guide to Language, Narrative and Concepts
Raez, Luis
Raez LE, Santos ES, Rolfo C, et al. Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America. Clin Lung Cancer. 2017;18(1):e71-e79.
Raez LE, Cardona AF, Santos ES, et al. The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments. Lung Cancer. 2018;119:7-13.
Raez LE, Nogueira A, Santos ES, et al. Challenges in Lung Cancer Screening in Latin America. J Glob Oncol. 2018;4:1-10.
Pinto JA, Raez LE. Old myths about old patients: the case of non-small cell lung cancer. Transl Lung Cancer Res. 2018;7(Suppl 4):S362-S363.
Johnstone, Peter
Johnstone PA, Kane CJ, Sun L, et al. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002;225(2):420-426.
Beitinjaneh, Amer Morris
Wood WA, Brazauskas R, Hu ZH, et al. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. Biol Blood Marrow Transplant. 2018;24(9):1928-1935.
Blanquicett, Carmelo J
Blanquicett C, Cohen JB, Flowers C, Johnson T 2nd. The Role of the Comprehensive Geriatric Assessment in the Evaluation of the Older Cancer Patient. Oncology (Williston Park). 2019;33(11):687524. Published 2019 Nov 14.
Farooqi, Bilal
Farooqi B, Smith B, Chowdhary M, Pavoni S, Modi A, Schnell F. Racial disparities in breast cancer diagnosis in Central Georgia in the United States. J Community Support Oncol. 2015;13(12):436-441.
Sanchez, Julian A
Schabath MB, Blackburn CA, Sutter ME, et al. National Survey of Oncologists at National Cancer Institute-Designated Comprehensive Cancer Centers: Attitudes, Knowledge, and Practice Behaviors About LGBTQ Patients With Cancer. J Clin Oncol. 2019;37(7):547-558.
Quinn GP, Sanchez JA, Sutton SK, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384-400.
Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers’ knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016;99(10):1676-1684.
Schabath MB, Curci MB, Kanetsky PA, et al. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017;13(8):542-546.
Ailawadhi, Sikander
Ganguly S, Mailankody S, Ailawadhi S. Many Shades of Disparities in Myeloma Care. Am Soc Clin Oncol Educ Book. 2019;39:519-529.
Ailawadhi S, Parikh K, Abouzaid S, et al. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis. Blood Adv. 2019;3(20):2986-2994.
Ailawadhi S, Jacobus S, Sexton R, et al. Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials. Blood Cancer J. 2018;8(7):67.
Ailawadhi S, Frank RD, Sharma M, et al. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities. Cancer. 2018;124(8):1710-1721.
Rand KA, Song C, Dean E, et al. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev. 2016;25(12):1609-1618.
Ailawadhi S, Frank RD, Advani P, et al. Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis. Cancer Med. 2017;6(12):2876-2885.
Ailawadhi S, Azzouqa AG, Hodge D, et al. Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities. Clin Lymphoma Myeloma Leuk. 2019;19(10):619-623.
Nahleh, Zeina
Nahleh Z, Otoukesh S, Mirshahidi HR, et al. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics. Cancer Med. 2018;7(6):2710-2717.
Nik-Ahd F
Nik-Ahd F, De Hoedt AM, Butler C, et al. Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen. JAMA. Published online June 26, 2024. doi:10.1001/jama.2024.9997. https://jamanetwork.com/journals/jama/article-abstract/2820386?guestAccessKey=ee1568ca-cb3e-47e3-a62e-d8b58241f533
Charlot M
Charlot M, Stein JN, Damone E, Wood I, Forster M, Baker S, Emerson M, Samuel-Ryals C, Yongue C, Eng E, Manning M, Deal A, Cykert S. Effect of an Antiracism Intervention on Racial Disparities in Time to Lung Cancer Surgery. J Clin Oncol. 2022 Feb 14:JCO2101745. doi: 10.1200/JCO.21.01745.
Schatz, A. A., Brooks-Coley, K., Harrington, E., Murray, M. S., & Carlson, R. W.
Schatz, A. A., Brooks-Coley, K., Harrington, E., Murray, M. S., & Carlson, R. W. (2022). Patient, Caregiver, and Oncologist Experiences With and Perceptions of Racial Bias and Discrimination in Cancer Care Delivery, Journal of the National Comprehensive Cancer Network, 20(10), 1092-1098.e2. from https://jnccn.org/view/journals/jnccn/20/10/article-p1092.xml
© 2021 FLASCO | Premium Website Design by The HDG
